Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of HIST1H1C protein | affects expression | 20106945
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of HIST1H1C mRNA | increases expression | 18687144
|
D001554 |
Benzene |
Benzene results in decreased expression of HIST1H1C mRNA | decreases expression | 15122651 15120971
|
D019324 |
beta-Naphthoflavone |
beta-Naphthoflavone results in increased expression of HIST1H1C mRNA | increases expression | 19737606
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of HIST1H1C mRNA | increases expression | 20106945 20064835
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of HIST1H1C mRNA | decreases expression | 17944540
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of HIST1H1C mRNA | increases expression | 20382639
|
D016572 |
Cyclosporine |
Cyclosporine affects the expression of HIST1H1C mRNA | affects expression | 20106945
|
C014347 |
decitabine |
[decitabine co-treated with vorinostat] affects the expression of HIST1H1C mRNA | affects cotreatment|affects expression | 17330099
|
D004317 |
Doxorubicin |
HIST1H1C protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D004958 |
Estradiol |
Estradiol results in increased expression of HIST1H1C mRNA | increases expression | 20106945
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of HIST1H1C mRNA | affects cotreatment|increases expression | 17404688
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of HIST1H1C mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of HIST1H1C mRNA | decreases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of HIST1H1C mRNA | affects cotreatment|decreases expression | 17942748
|
C056933 |
fumonisin B1 |
fumonisin B1 results in increased expression of HIST1H1C mRNA | increases expression | 16221962
|
C029424 |
hydrazine |
hydrazine results in increased expression of HIST1H1C mRNA | increases expression | 15282401
|
C027185 |
indirubin |
indirubin results in decreased phosphorylation of HIST1H1C protein | decreases phosphorylation | 18344322
|
C027185 |
indirubin |
[tanshinone co-treated with tetraarsenic tetrasulfide] promotes the reaction [indirubin results in decreased phosphorylation of HIST1H1C protein] | affects cotreatment|decreases phosphorylation|increases reaction | 18344322
|
C027185 |
indirubin |
tanshinone promotes the reaction [indirubin results in decreased phosphorylation of HIST1H1C protein] | decreases phosphorylation|increases reaction | 18344322
|
C027185 |
indirubin |
tetraarsenic tetrasulfide promotes the reaction [indirubin results in decreased phosphorylation of HIST1H1C protein] | decreases phosphorylation|increases reaction | 18344322
|
D007529 |
Isoflavones |
Isoflavones affects the expression of HIST1H1C mRNA | affects expression | 16365062
|
C452423 |
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine |
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine results in increased expression of HIST1H1C mRNA | increases expression | 16052530
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of HIST1H1C mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of HIST1H1C mRNA | increases expression | 19482888
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of HIST1H1C mRNA | increases expression | 20059764 18445702
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in increased expression of HIST1H1C mRNA] | increases expression|increases reaction | 20059764
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of HIST1H1C mRNA | affects cotreatment|increases expression | 17404688
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of HIST1H1C mRNA | affects expression | 17555576
|
C021751 |
tanshinone |
[tanshinone co-treated with tetraarsenic tetrasulfide] promotes the reaction [indirubin results in decreased phosphorylation of HIST1H1C protein] | affects cotreatment|decreases phosphorylation|increases reaction | 18344322
|
C021751 |
tanshinone |
tanshinone promotes the reaction [indirubin results in decreased phosphorylation of HIST1H1C protein] | decreases phosphorylation|increases reaction | 18344322
|
C534735 |
tetraarsenic tetrasulfide |
[tanshinone co-treated with tetraarsenic tetrasulfide] promotes the reaction [indirubin results in decreased phosphorylation of HIST1H1C protein] | affects cotreatment|decreases phosphorylation|increases reaction | 18344322
|
C534735 |
tetraarsenic tetrasulfide |
tetraarsenic tetrasulfide promotes the reaction [indirubin results in decreased phosphorylation of HIST1H1C protein] | decreases phosphorylation|increases reaction | 18344322
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of HIST1H1C mRNA | increases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of HIST1H1C mRNA | affects cotreatment|decreases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of HIST1H1C mRNA | decreases expression | 17942748 19465110
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of HIST1H1C mRNA | increases expression | 16249480
|
D014747 |
Vinblastine |
HIST1H1C protein affects the susceptibility to Vinblastine | affects response to substance | 16217747
|
C111237 |
vorinostat |
[decitabine co-treated with vorinostat] affects the expression of HIST1H1C mRNA | affects cotreatment|affects expression | 17330099
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.34 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
7.59 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.59 | 15322242 14514962 11752688 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.73 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.92 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
9.71 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
9.71 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.71 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
9.71 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.41 | 6695378 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
6.41 | 19389873 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
16.06 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
16.06 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
16.06 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.34 | 21441931 |
MESH:D000505 |
Alopecia |
|
Isoflavones |
9.03 | 17569567 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
9.03 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.76 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
4.21 | 11369114 14761424 17661222 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.87 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.26 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.78 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.78 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.22 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.28 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.20 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
14.17 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
14.17 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
14.17 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.58 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.63 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
5.02 | 16183116 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.49 | 14601052 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.13 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.05 | 15665606 15845082 15380490 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.63 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 17659439 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
8.07 | 17162533 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
8.07 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
8.07 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
8.07 | 18695136 16322301 15136595 15994142 15939500 17983394 16264153 15634643 18628466 16826403 19526202 16935488 16096432 18382427 18234424 17369602 15993339 11325840 16115903 15668708 15692762 17426702 16595493 15567936 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
8.07 | 17289903 19861407 16675129 17018787 12948864 18497071 17261762 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
8.07 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
8.07 | 15565566 20390343 20135344 20065188 19011961 16818667 19155303 17261762 21138602 21152245 18855134 19200415 19189210 17440819 11161223 16873071 19221464 19487384 17893378 19410462 18351453 20005174 16202921 17242785 19189212 18425577 18815881 18984771 19084267 19289846 19115204 17049068 20544844 18997820 19142967 20859285 15668708 19288272 18629630 19103187 19244106 18821012 19059307 19066611 16273361 |
MESH:D001943 |
Breast Neoplasms |
|
tanshinone |
8.07 | 15849732 19885617 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
8.07 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
8.07 | 16166294 16443354 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
vorinostat |
8.07 | 16144943 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.38 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.25 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.60 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.63 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.30 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.95 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
10.93 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
10.93 | 18059187 17876044 16234567 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
10.93 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
10.93 | 17173139 20935162 1701930 6705139 20007298 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
10.93 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
10.93 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.63 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Vinblastine |
6.63 | 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
10.29 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
10.29 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
10.29 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
10.29 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.43 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.25 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.39 | 16278810 17308081 16952015 16109756 17382496 16364871 17974986 17351982 17924179 18627295 16455267 15476868 15792986 16269455 17928571 16731534 15811867 16651473 16242529 17519947 17329180 15505089 17131338 16612575 17007740 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.87 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Isoflavones |
4.01 | 17689850 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.97 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.31 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
10.31 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
10.31 | 18566989 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.04 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.38 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
12.45 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
12.45 | 17681005 11677210 16105132 15861022 16919318 17333356 17110522 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
12.45 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.95 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.47 | 12621046 15340226 15668235 8697196 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.47 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.50 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.30 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
4.73 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
4.73 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Isoflavones |
4.73 | 17116718 |
MESH:D015179 |
Colorectal Neoplasms |
|
Vinblastine |
4.73 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.88 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
3.70 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.70 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.70 | 8800419 17551590 9664655 10589399 14991402 16925845 9211117 9224671 9142499 9125849 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.15 | 19031437 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.56 | 15902427 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.33 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.62 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.25 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
8.25 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.28 | 17187935 |
MESH:D003967 |
Diarrhea |
|
vorinostat |
4.30 | 20479100 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
5.99 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
fumonisin B1 |
5.99 | 16221962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.99 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.60 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.60 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.81 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
5.92 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.92 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.23 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.23 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
14.15 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
14.15 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
14.15 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.90 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
16.67 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
16.67 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
16.67 | 19155303 20544844 17893378 16202921 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
16.67 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.32 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.32 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.94 | 18037988 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.90 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.66 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.78 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.37 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.04 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.81 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.16 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.16 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.32 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.32 | 16938888 9664655 |
MESH:D005221 |
Fatigue |
|
vorinostat |
5.38 | 20479100 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
17.17 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
17.17 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
17.17 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
17.17 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.11 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.25 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.32 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
10.74 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
10.74 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.52 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.52 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
13.52 | 17994277 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.01 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
6.79 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.79 | 17312396 |
MESH:D005910 |
Glioma |
|
tanshinone |
3.94 | 16955220 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.38 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
12.18 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
12.18 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
12.18 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.95 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.46 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.46 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.46 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.34 | 16495754 17888722 18006777 16244371 14766674 18674790 16244372 16144979 17875725 16330681 16879835 12587719 16707910 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.62 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.62 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.71 | 15692506 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.46 | 16183116 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.21 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.15 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
fumonisin B1 |
19.00 | 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
19.00 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
19.00 | 19772884 16221962 19176532 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
19.00 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.82 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
7.22 | 18501091 17606976 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
Vinblastine |
7.22 | 18501091 18180244 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
9.71 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Isoflavones |
9.71 | 14716179 17290160 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.83 | 18606429 15340226 16354765 8697196 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.05 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.36 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.00 | 20558911 |
MESH:D006968 |
Hypersensitivity, Delayed |
|
indirubin |
5.72 | 11275354 |
MESH:D006973 |
Hypertension |
|
Benzene |
8.14 | 17940673 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.14 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.14 | 18670907 18850075 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
tanshinone |
5.05 | 19662366 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.60 | 16569931 16945680 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.19 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.27 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
6.26 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.26 | 17937319 |
MESH:D007249 |
Inflammation |
|
Progesterone |
7.67 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
7.67 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.67 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.75 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.75 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.56 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.30 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.30 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.23 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.39 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
9.39 | 15699352 16775033 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.39 | 15618244 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
3.96 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.39 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.39 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
11.39 | 18625569 |
MESH:D007938 |
Leukemia |
|
Benzene |
9.98 | 14694614 17119257 18335105 15935818 |
MESH:D007938 |
Leukemia |
|
decitabine |
9.98 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
9.98 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.94 | 16085563 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
tetraarsenic tetrasulfide |
4.89 | 19208803 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
14.98 | 17506065 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
14.98 | 18454857 19117987 17236224 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
14.98 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
marker/mechanism |
|
| 17330099 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
5.99 | 19478238 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
5.99 | 19387464 18206229 18704418 19010910 18460780 17679729 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
5.99 | 16294345 17596541 19850784 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.25 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.02 | 19075265 16935935 17339181 17301526 17649720 19029980 17361223 19225113 17107899 16140955 9834237 17506722 17712046 12679006 16823087 15748426 16788101 17217047 17294898 16331271 16891316 16766008 19642359 17368321 19035177 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.16 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.01 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
2.78 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
8.38 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
8.38 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
8.38 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
8.38 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.38 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
8.38 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.12 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
20.67 | 18177683 9163691 15890375 2125692 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
20.67 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
20.67 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
20.67 | 19812893 15975961 19482888 19073162 8742319 21047994 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
20.67 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
20.67 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
20.67 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
21.69 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
21.69 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
21.69 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
21.69 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
21.69 | 6150874 18308698 2563599 17172636 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
21.69 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.60 | 14698565 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.82 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
8.21 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
8.21 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
8.21 | 17053015 18569708 18520028 20464547 6695378 18816296 20135361 20869020 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
8.21 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
8.21 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.21 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Benzene |
11.81 | 17584886 17119257 |
MESH:D008223 |
Lymphoma |
|
decitabine |
11.81 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
11.81 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.62 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.36 | 15621674 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
vorinostat |
5.48 | 20479100 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
9.37 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
9.37 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
17.41 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
17.41 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
17.41 | 11807958 16891317 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
17.41 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
17.41 | 19196722 14580682 19196723 11731420 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.94 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.94 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.70 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
9.40 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
9.40 | 16827129 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
9.40 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
9.40 | 16752155 |
MESH:D008545 |
Melanoma |
|
Vinblastine |
9.40 | 18176117 16809738 12374674 16432458 18332650 15577323 15577320 18505091 17761969 16248763 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.97 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.22 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
6.16 | 16966607 16166281 18303189 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.16 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.58 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.31 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.03 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.58 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
7.09 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
7.09 | 18172295 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.30 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.08 | 19010910 16882708 19157545 18608210 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.08 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.42 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.42 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.85 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.72 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.72 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.26 | 17484760 |
MESH:D009325 |
Nausea |
|
vorinostat |
5.31 | 20479100 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.59 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.59 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.45 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
11.00 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
11.00 | 19116145 17925555 19470736 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
11.00 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
11.00 | 16594593 16946489 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.79 | 19200415 19189210 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.52 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.56 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.23 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
8.71 | 18481113 19348381 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
8.71 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
15.16 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.16 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
15.16 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
7.06 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.06 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.16 | 15555623 |
MESH:D009503 |
Neutropenia |
|
Vinblastine |
4.38 | 17378895 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.76 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
4.00 | 15935809 17119257 15612468 15576619 15727169 17178637 16737584 17479406 15913788 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.15 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Isoflavones |
3.97 | 16562857 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.95 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
14.27 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
14.27 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
14.27 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
14.27 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
14.27 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.74 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
8.21 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
8.21 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.21 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.49 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.04 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.94 | 17983394 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.69 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.94 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.36 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.38 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
8.38 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.98 | 11896295 11399792 11118676 11222880 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.52 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.69 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.89 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
1.89 | 16868541 15897917 16888761 16729912 15749863 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.89 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Isoflavones |
1.89 | 17219775 17571952 17374662 16365062 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.89 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
vorinostat |
1.89 | 17218635 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.41 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.10 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.28 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.16 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.58 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
2.95 | 17322281 17365031 15814490 17975199 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.01 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.29 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.64 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
10.30 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.30 | 16116481 16283617 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.78 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.81 | 16767912 15675481 15625365 17710206 17203757 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.04 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.58 | 17846226 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.56 | 3137016 4039156 11442880 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.61 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
12.75 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
12.75 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.75 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
12.75 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.36 | 17203757 15625365 16767912 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.85 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.85 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
10.17 | 16503802 15862959 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
10.17 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
4.57 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.57 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
4.57 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.57 | 17261132 |
MESH:D013921 |
Thrombocytopenia |
|
vorinostat |
4.79 | 20479100 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.42 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.98 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.74 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.69 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
20.83 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
20.83 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine |
20.83 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
20.83 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
20.83 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.47 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.60 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.10 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.27 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
11.27 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
11.27 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
11.27 | 16712894 17572228 8653321 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.49 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
8.90 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
8.90 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
12.12 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
12.12 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.77 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Vinblastine |
4.84 | 15577323 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.38 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.35 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.01 | 16364871 17678736 17638931 17334414 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.85 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.04 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.79 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.23 | 17120751 |